Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.95
-0.52 (-1.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,435 | 1,994 | - | - | - |
| Enterprise Value | 1,116 | 1,634 | - | - | - |
| Last Close Price | 25.95 | 41.43 | - | - | - |
| PB Ratio | 3.61 | 5.62 | - | - | - |
| P/TBV Ratio | 4.04 | 5.62 | - | - | - |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.14 | 4.94 | 0.32 |
| Debt / EBITDA Ratio | - | - | 0.40 | - | - |
| Debt / FCF Ratio | - | - | 0.36 | - | - |
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.86 | 2.04 | -0.67 |
| Net Debt / EBITDA Ratio | 2.27 | 2.27 | -2.79 | -0.22 | 0.63 |
| Net Debt / FCF Ratio | 2.83 | 2.83 | -2.27 | -0.23 | 0.67 |
| Asset Turnover | - | - | 1.07 | - | - |
| Quick Ratio | 15.23 | 15.23 | 9.52 | 1.79 | 4.81 |
| Current Ratio | 15.50 | 15.50 | 9.76 | 2.09 | 5.11 |
| Return on Equity (ROE) | -47.52% | -47.52% | 50.48% | -180.12% | - |
| Return on Assets (ROA) | -28.01% | -28.01% | 23.07% | -55.63% | - |
| Return on Invested Capital (ROIC) | -510.00% | -453.11% | 196.80% | -307.50% | -330.64% |
| Return on Capital Employed (ROCE) | -38.20% | -38.20% | 26.20% | -178.60% | -86.00% |
| Earnings Yield | -9.14% | -6.58% | - | - | - |
| FCF Yield | -7.86% | -5.66% | - | - | - |
| Buyback Yield / Dilution | -1474.04% | -1474.04% | -19.33% | -13.82% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.